title: Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
authors.affiliation: CHRU de Tours, Service de Réanimation Polyvalente, F-37000, Tours, France. antoine.guillon@univ-tours.fr.|INSERM, Centre d'Étude des Pathologies Respiratoires, U1100, F-37032, Tours, France. antoine.guillon@univ-tours.fr.|Université François Rabelais de Tours, F-37032, Tours, France. antoine.guillon@univ-tours.fr.
authors.forename: Antoine
authors.identifier: http://orcid.org/0000-0002-4884-8620
authors.initials: A
authors.lastname: Guillon
authors.affiliation: City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
authors.forename: Karen L
authors.initials: KL
authors.lastname: Reckamp
authors.affiliation: INSERM, Centre d'Étude des Pathologies Respiratoires, U1100, F-37032, Tours, France.|Université François Rabelais de Tours, F-37032, Tours, France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Heuzé-Vourc'h
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000592:standards*; D007362:Intensive Care Units / Q000458:organization & administration; D011379:Prognosis; D016896:Treatment Outcome; D014218:Triage / Q000379:methods / Q000639:trends*